Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.19.3
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Income Statement [Abstract]        
Revenue   $ 254 $ 37 $ 630
Operating expenses:        
Research and development $ (28,066) (22,583) (69,892) (47,188)
General and administrative (2,933) (2,657) (8,988) (6,058)
Total operating expenses (30,999) (25,240) (78,880) (53,246)
Operating loss (30,999) (24,986) (78,843) (52,616)
Interest expense, net (216) (138) (455) (100)
Other income, net 48 328 204 183
Total other (expense) / income (168) 190 (251) 83
Loss before income taxes (31,167) (24,796) (79,094) (52,533)
Income tax expense (104) (109) (395) (266)
Net loss and comprehensive loss (31,271) (24,905) (79,489) (52,799)
Net loss attributable to ordinary shareholders $ (31,271) $ (24,905) $ (79,489) $ (52,799)
Net loss per share attributable to ordinary shareholders – basic and diluted $ (2.15) $ (1.77) $ (5.52) $ (7.42)
Weighted average ordinary shares outstanding – basic and diluted 14,571,278 14,034,631 14,412,755 7,115,655